Beta-Glucan (Oat)
Also known as: oat beta-glucan, OBG
Multiple randomized trials and meta-analyses report that ≥3 g/day oat beta-glucan lowers LDL and total cholesterol modestly. Acute feeding trials pooled in meta-analysis show dose- and molecular-weight–dependent reductions in postprandial glucose and insulin responses.
Last reviewed: 2026-10-14 · 5 indexed studies
Set your location for accurate regulatory status
Saved on this device — no sign-in needed.
Overview
Oat beta-glucan is a viscous, soluble fibre from oats commonly consumed in foods or as concentrated extracts. Human trials and meta-analyses show consistent reductions in LDL and total cholesterol at intakes around 3 g/day and dose-dependent reductions in postprandial glucose and insulin when added to carbohydrate-containing meals.
Mechanism & Function
Mechanism of Action
As a viscous soluble fibre, oat beta-glucan increases the viscosity of intestinal contents which slows carbohydrate absorption and reduces bile acid recirculation; this can lower postprandial glycaemia and reduce circulating LDL cholesterol through altered cholesterol/bile acid metabolism.
Physiological Role
Modulates intestinal viscosity and transit, reduces rate of glucose absorption, and influences cholesterol metabolism via bile acid binding and reduced enterohepatic recirculation.
Primary Pathways
Performance / Health Relevance
Not an ergogenic agent. May be relevant to metabolic and cardiovascular risk management through modest cholesterol lowering and improved postprandial glycaemia.
Evidence Review
Practical Use & Dosage
- Minimum Effective Dose
- ≥3 g/day for LDL and total cholesterol lowering; lower doses can produce acute reductions in postprandial glucose in a dose-dependent manner.
- Optimal Range
- 3–4 g/day for cholesterol outcomes in trials; acute dose-response reported for glycaemic effects (specific effective acute doses varied across studies).
- Upper / Caution Level
- Not established
- Timing
- For glycaemic effects, consumed with carbohydrate-containing meals; for cholesterol lowering, daily intake (~3 g/day) as part of the habitual diet.
- Best Format
- Whole-oat foods, concentrated oat beta-glucan extracts, beverages delivering specified grams of OBG.
- Bioavailability
- Functional effect depends on molecular weight; higher molecular-weight OBG (>300 kg/mol) produced larger reductions in postprandial glucose in pooled trials.
- Absorption Considerations
- Beta-glucan acts in the gut and is not systemically absorbed; effects depend on viscosity and dose.
Safety & Interactions
Side Effects
- •Transient gastrointestinal symptoms (e.g. bloating, flatulence) reported in trials
Monitoring
Monitor gastrointestinal tolerance when initiating or increasing intake.
Frequently Asked Questions
Auto-generated from indexed evidence — dosage, safety, interactions, and more.
When is Beta-Glucan (Oat) typically used or indicated?
Beta-Glucan (Oat) is most commonly used for: Cholesterol management, Postprandial blood glucose control, General soluble-fibre supplementation. Modulates intestinal viscosity and transit, reduces rate of glucose absorption, and influences cholesterol metabolism via bile acid binding and reduced enterohepatic recirculation.
How does Beta-Glucan (Oat) work?
As a viscous soluble fibre, oat beta-glucan increases the viscosity of intestinal contents which slows carbohydrate absorption and reduces bile acid recirculation; this can lower postprandial glycaemia and reduce circulating LDL cholesterol through altered cholesterol/bile acid metabolism.
What is the recommended dose of Beta-Glucan (Oat)?
The optimal range is 3–4 g/day for cholesterol outcomes in trials; acute dose-response reported for glycaemic effects (specific effective acute doses varied across studies).. with a minimum effective dose of ≥3 g/day for LDL and total cholesterol lowering; lower doses can produce acute reductions in postprandial glucose in a dose-dependent manner.. Best taken: For glycaemic effects, consumed with carbohydrate-containing meals; for cholesterol lowering, daily intake (~3 g/day) as part of the habitual diet.. Upper / caution level: Not established.
What are the side effects of Beta-Glucan (Oat)?
Reported side effects include: Transient gastrointestinal symptoms (e.g. bloating, flatulence) reported in trials. Monitoring: Monitor gastrointestinal tolerance when initiating or increasing intake.
How strong is the evidence for Beta-Glucan (Oat)?
Evidence level: Strong (overall score 77/100), based on 5 indexed studies on SuppIndex.
Research & References (5)
Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Systematic review and meta-analysis of 13 RCTs in hypercholesterolaemic adults assessing effects of oat beta-glucan on serum lipids.
The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials.
Large systematic review and meta-analysis of 58 RCTs (median dose 3.5 g/day) assessing oat beta-glucan effects on LDL, non-HDL and apoB.
Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials.
Meta-analysis of 28 RCTs comparing ≥3 g/day oat beta-glucan with control, quantifying effects on serum cholesterol.
An Oat β-Glucan Beverage Reduces LDL Cholesterol and Cardiovascular Disease Risk in Men and Women with Borderline High Cholesterol: A Double-Blind, Randomized, Controlled Clinical Trial.
Double-blind RCT in adults with borderline-high LDL comparing a beverage providing 3 g/day high-MW OBG (1 g three times daily) versus placebo for 4 weeks.
The effect of oat β-glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis.
Systematic review and meta-analysis of acute, controlled feeding trials (103 comparisons, N=538) on OBG added to carbohydrate meals examining postprandial glucose and insulin.
Related Ingredients
Other top-rated ingredients in General Health Ingredients.
Piperine
82/100A piperidine alkaloid (C₁₇H₁₉NO₃) that inhibits cytochrome P450 enzymes (CYP3A4, CYP1A2, CYP2E1), P-glycoprotein efflux transporters, and UDP-glucuronosyltransferases while enhancing intestinal permeability, digestive enzyme secretion, and splanchnic blood flow — collectively producing dramatic improvements in nutrient bioavailability.
CoQ10
78/100Endogenous lipid-soluble ubiquinone/ubiquinol that shuttles electrons in the mitochondrial respiratory chain and acts as a membrane antioxidant.
Cinnamon
75/100Randomized trials and meta-analyses report that cinnamon supplementation can lower fasting glucose, HbA1c and some insulin-resistance measures in people with type 2 diabetes and can reduce measures of body weight and waist circumference in some trials. Individual trial results vary and heterogeneity between studies is noted.
Research Overview
Strong EvidenceCite this ingredient
One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.
Stable URL
https://thesuppindex.com/ingredients/beta-glucan-oat
SuppIndex. (2026). Beta-Glucan (Oat): Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/beta-glucan-oat
Based on 5 indexed studies · Evidence level: Strong.
Goal Ratings
Stack Compatibility
Can be used as part of a high-fibre diet or with other dietary approaches for cholesterol or glycaemic management; product molecular-weight and delivered dose matter for efficacy.